Chinese group tourists lift hopes for Korean fashion, pharma firms

4.8 (788) ·

$ 9.99 ·

In stock

Description

Asian tourism-focused businesses ready for China rebound as border reopens

Weekly Market Commentary

LVMH Tops $22 Billion Luxury Rally as China Lifts Travel Ban

Chinese Company Aims to Sell 3 U.S. Resorts for $1.3 Billion - WSJ

China's pharmaceutical industry will be at the global forefront in the next 5 years, Fosun Pharma chairman says

Healing Over Hope: 5 Shifts for Impact in a Fight or Flight World

Insights: Global Entertainment and Media Outlook 2023–2027

Japan Firms Brace for Hidden Risks under China's New Anti-Spy Law - The Japan News

Coronavirus: World leaders and drugmakers weigh in on patent waiver proposal - as it happened

China Reopens to the World as International Travel Restrictions End - WSJ

Fosun and BioNTech to develop vaccine targeting omicron - Nikkei Asia

WEEK IN REVIEW: US apparel sector doubling down on China sourcing shift - Just Style